HLA-DRA encodes the HLA class II histocompatibility antigen DR alpha chain, a core subunit of MHC class II complexes. It heterodimerizes with DR beta chains (e.g., DRB1) to form functional antigen-presenting molecules, which bind exogenous peptides and present them to CD4+ T lymphocytes, triggering adaptive immune responses against pathogens.
Genetic variants of HLA-DRA are associated with autoimmune disorders like rheumatoid arthritis and systemic lupus erythematosus, as altered antigen presentation may drive self-reactivity. While direct drugs targeting HLA-DRA are limited, therapies modulating MHC class II-mediated T cell activation (e.g., co-stimulatory blockers) are used or in development, capitalizing on its role in immune regulation for disease management.
Recombinant Human HLA class II histocompatibility antigen, DR alpha chain (HLA-DRA) (CSB-EP360793HU)
Validated Data
(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
HLA-DRA Recombinant Monoclonal Antibody (CSB-RA188867A0HU)
Validated Data
Western Blot
Positive WB detected in: Raji whole cell lysate(30µg)
All lanes: HLA DRA antibody at 1:1000
Secondary
Goat polyclonal to rabbit IgG at 1/40000 dilution
Predicted band size: 29 kDa
Observed band size: 35 kDa
Exposure time:2min40s
Human HLA class II histocompatibility antigen, DR alpha chain (HLA-DRA) ELISA kit (CSB-EL010497HU)
Validated Data
Code: CSB-EL010497HU
Size: 96T,5×96T,10×96T
Sensitivity: 4.68 pg/mL
Detection Range: 18.75 pg/mL-1200 pg/mL
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
The following HLA-DRA reagents supplied by CUSABIO are manufactured under a strict quality control system. Multiple applications have been validated and solid technical support is offered.
HLA-DRA Antibodies for Homo sapiens (Human)
| Code | Product Name | Species Reactivity | Application |
|---|---|---|---|
| CSB-PA17939C0Rb | HLA-DRA Antibody, FITC conjugated | Human | |
| CSB-PA17939A0Rb | HLA-DRA Antibody | Human | ELISA, IHC |
| CSB-PA17939B0Rb | HLA-DRA Antibody, HRP conjugated | Human | ELISA |
| CSB-RA188867A0HU | HLA-DRA Recombinant Monoclonal Antibody | Human | ELISA, WB |
HLA-DRA Proteins for Homo sapiens (Human)
| Code | Product Name | Source |
|---|---|---|
| CSB-YP360793HU | Recombinant Human HLA class II histocompatibility antigen, DR alpha chain (HLA-DRA) | Yeast |
| CSB-EP360793HU | Recombinant Human HLA class II histocompatibility antigen, DR alpha chain (HLA-DRA) | E.coli |
| CSB-BP360793HU CSB-MP360793HU CSB-EP360793HU-B |
Recombinant Human HLA class II histocompatibility antigen, DR alpha chain (HLA-DRA) | Baculovirus Mammalian cell In Vivo Biotinylation in E.coli |
| CSB-EP360793HU1 | Recombinant Human HLA class II histocompatibility antigen, DR alpha chain (HLA-DRA), partial | E.coli |
HLA-DRA ELISA Kit for Homo sapiens (Human)
| Code | Product Name | Sample Types | Sensitivity |
|---|---|---|---|
| CSB-EL010497HU | Human HLA class II histocompatibility antigen, DR alpha chain (HLA-DRA) ELISA kit | serum, plasma, tissue homogenates | 4.68 pg/mL |